Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Multiple Sclerosis

  Free Subscription


29.11.2021

2 Acta Neurol Scand
1 J Immunol
2 J Neuroimmunol
2 J Neurol
1 J Neurol Neurosurg Psychiatry
2 Lancet Neurol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neurol Scand

  1. SMYRKE N, Dunn N, Murley C, Mason D, et al
    Standardized mortality ratios in multiple sclerosis: Systematic review with meta-analysis.
    Acta Neurol Scand. 2021 Nov 24. doi: 10.1111/ane.13559.
    PubMed         Abstract available

  2. THEODORSDOTTIR A, Larsen PV, Nielsen HH, Illes Z, et al
    Multiple sclerosis impairment scale and brain MRI in secondary progressive multiple sclerosis.
    Acta Neurol Scand. 2021 Nov 19. doi: 10.1111/ane.13554.
    PubMed         Abstract available


    J Immunol

  3. O'CONNELL P, Blake MK, Godbehere S, Aldhamen YA, et al
    Absence of ERAP1 in B Cells Increases Susceptibility to Central Nervous System Autoimmunity, Alters B Cell Biology, and Mechanistically Explains Genetic Associations between ERAP1 and Multiple Sclerosis.
    J Immunol. 2021 Nov 22. pii: jimmunol.2100813. doi: 10.4049/jimmunol.2100813.
    PubMed         Abstract available


    J Neuroimmunol

  4. CARAVAGNA C
    Comments on "Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine" by , J Neuroimmunol.
    J Neuroimmunol. 2021;362:577780.
    PubMed        

  5. HASSANSHAHI G, Noroozi Karimabad M, Jebali A
    The therapeutic effect of PEGlated nanoliposome of pistachio unsaturated oils and its efficacy to attenuate inflammation in multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial phase I.
    J Neuroimmunol. 2021;362:577768.
    PubMed         Abstract available


    J Neurol

  6. SRIWASTAVA S, Chaudhary D, Srivastava S, Beard K, et al
    Progressive multifocal leukoencephalopathy and sphingosine 1-phosphate receptor modulators used in multiple sclerosis: an updated review of literature.
    J Neurol. 2021 Nov 20. pii: 10.1007/s00415-021-10910.
    PubMed         Abstract available

  7. RIO J, Rovira A, Gasperini C, Tintore M, et al
    Correction to: Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing-remitting multiple sclerosis patients.
    J Neurol. 2021 Nov 20. pii: 10.1007/s00415-021-10906.
    PubMed        


    J Neurol Neurosurg Psychiatry

  8. PREZIOSA P, Pagani E, Bonacchi R, Cacciaguerra L, et al
    In vivo detection of damage in multiple sclerosis cortex and cortical lesions using NODDI.
    J Neurol Neurosurg Psychiatry. 2021 Nov 19. pii: jnnp-2021-327803.
    PubMed         Abstract available


    Lancet Neurol

  9. SORMANI MP, Waubant E
    Paediatric multiple sclerosis: a lesson from TERIKIDS.
    Lancet Neurol. 2021;20:971-973.
    PubMed        

  10. CHITNIS T, Banwell B, Kappos L, Arnold DL, et al
    Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial.
    Lancet Neurol. 2021;20:1001-1011.
    PubMed         Abstract available


    PLoS One

  11. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: